Comparisons of the Risks of New-Onset Prostate Cancer in Type 2 Diabetes Mellitus Between SGLT2I and DPP4I Users: a Population-Based Cohort Study
Diabetes & Metabolism(2024)
Key words
Dipeptidyl peptidase-4 inhibitors,Glucagon-like peptide-1 receptor agonist,Prostate,Prostate cancer,Sodium-glucose cotransporter 2 inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined